Calcyclin, b-actin and H3-histone expression is modulated by sex steroids in hormone dependent human mammary cells (CG5)
1996-01-01 GHEZZO F; G. BERTA; D'AVOLIO A; RACCA S; CONTI G; DI CARLO F
Changes in the binding of oestradiol to uterine oestrogen receptors induced by some progesterone and 19-nor-testosterone derivatives.
1983-01-01 DI CARLO F ;GALLO E ;CONTI G ;RACCA S
Correlation between pS2 protein positivity, steroid receptor status and other prognostic factors in breast cancer.
1995-01-01 RACCA S ;CONTI G ;PIETRIBIASI F ;STRAMIGNONI D ;TAMPELLINI M ;VALETTO MR ;GHEZZO F ;DI CARLO F
[Correlation of the biochemical and histochemical determination of hormone receptors in carcinoma of the breast with the age of the patient, stage and histologic type of the neoplasm]
1987-01-01 CAMPOBASSO O ;CONCINA S ;COZZANI C ;RIBOTTA M ;DI CARLO F ;CONTI G ;RACCA S
Correlations among receptor status, estrogen receptor (ER) form (8S and/or 4S) and labelling index (LI) in human breast cancer.
1990-01-01 BADINO P ;CONTI G ;GIUBERTONI M ;RACCA S ;DI CARLO F
[Distribution of estrogen receptors and progesterone receptors in the human uterus and influence of anesthetic drugs]
1982-01-01 RUSSO A ;MONDO F ;FRANCALANCI S ;DI CARLO F ;CONTI G ;RACCA S ;REBOANI C
Effects of bromocriptine and dopamine on the binding of estradiol to its uterine cytoplasmic receptors.
1983-01-01 GALLO E ;RACCA S ;CONTI G ;REBOANI C ;PORTALEONE P ;DI CARLO F
Effects of estrogens P-1496 and P-1560 on the binding of estradiol with rat uterine estrogen receptors.
1980-01-01 DI CARLO F ;CONTI G ;REBOANI C ;RACCA S
Effects of medroxyprogesterone acetate on DMBA-induced mammary tumors.
1985-01-01 RACCA S ;CONTI G ;CRISPINO A ;GALLO E ;DI CARLO F
Estrogen and progesterone receptors in the human vagina.
1985-01-01 DI CARLO F ;RACCA S ;GALLO E ;CONTI G ;RUSSO A ;MONDO F ;FRANCALANCI S
Histidine increases estrogen and progesterone receptor levels in rat mammary tumors.
1990-01-01 RACCA S ;BADINO P ;CAROZZI S ;CONTI G ;GIUBERTONI M ;SQUILLARIO P ;DI CARLO F
Histidine potentiates the antiproliferative effect of medroxyprogesterone acetate (MPA) on a human breast cancer cell line.
1990-01-01 GIUBERTONI M ;BADINO P ;CONTI G ;RACCA S ;DI CARLO F
Medroxyprogesterone acetate (MPA) stimulates adenylate cyclase activity in rat mammary tumours.
1989-01-01 S. RACCA; G. CONTI; G. MUCCIOLI; L. PARADISI; M. GIUBERTONI; P. BADINO; F. DI CARLO
Ormonal modulation of human calcyclin gene expression
1994-01-01 GHEZZO F; RACCA S; BERTA G N; CONTI G; DI CARLO F
Potentiation of medroxyprogesterone acetate antineoplastic activity by histidine in rat mammary tumours
1991-01-01 Di Carlo F; Conti G; Giubertoni Maura; Muccioli G; Racca S.
[Prognostic value of receptor state determined by radiometric method in breast carcinoma]
1985-01-01 CAMPOBASSO O ;CHASSEUR D ;CONCINA S ;CONTI G ;COZZANI C ;RACCA S
Relation between EGF-R levels and tumour response to endocrine treatment in DMBA-induced mammary tumour.
1998-01-01 Racca S; Abbadessa G; Gambino G; Conti G; Di carlo F.